Skip to content

Leonardo DRS, Inc.

US · DRS #1485 by market cap Listed 2021
31.27 -1.50 -4.58%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    CCORF Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2026/9/18
  • Rating change
    BTIG Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/11/3
  • Rating change
    CCORF Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/10/30
  • Press Release: Leonardo DRS Appoints Shaveta J. Kapoor as Chief Human Resources Officer
    Dow Jones · 2026/11/5
  • Rating change
    Morgan Stanley Initiates Leonardo DRS, Inc.(DRS.US) With Hold Rating, Announces Target Price $44
    Market Newswire · 2026/10/16
  • Company notice
    Leonardo DRS, Inc. | 4: Statement of changes in beneficial ownership of securities-Officer Dippold Michael
    SEC · 2026/11/4
  • Rating change
    J.P. Morgan Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Maintains Target Price $53
    Market Newswire · 2026/8/5
  • Leonardo DRS, Inc. Just Recorded A 25% EPS Beat: Here's What Analysts Are Forecasting Next
    Simply Wall St · 2026/11/1
  • Company notice
    Leonardo DRS, Inc. | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
    SEC · 2026/11/14
  • Leonardo DRS, Inc. To Go Ex-Dividend On November 12th, 2026 With 0.09 USD Dividend Per Share
    Market Newswire · 2026/11/11
  • Rating change
    Morgan Stanley Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Maintains Target Price $44
    Market Newswire · 2026/10/19
  • J.P. Morgan Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Cuts Target Price to $48
    Market Newswire · 2026/11/11
  • Company notice
    Optim: Optim has completed its first M&A deal in the healthcare sector, acquiring MediTech Co., Ltd., which provides the medical imaging sharing service "Drs' HotLine," as a subsidiary.
    JPX · 2026/11/2
  • Company notice
    Leonardo DRS, Inc. | 8-K: Leonardo DRS Announces Financial Results for Third Quarter 2026
    SEC · 2026/10/29
  • Rating change
    Goldman Sachs Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2026/11/3
  • Rating change
    Goldman Sachs Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Cuts Target Price to $53
    Market Newswire · 2026/10/12
  • Company notice
    Leonardo DRS, Inc. | 144: Notice of proposed sale of securities pursuant to Rule 144
    SEC · 2026/11/2
  • Rating change
    Morgan Stanley Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Maintains Target Price $45
    Market Newswire · 2026/11/2
  • There's A Lot To Like About Leonardo DRS' (NASDAQ:DRS) Upcoming US$0.09 Dividend
    Simply Wall St · 2026/11/7
  • Rating change
    Goldman Sachs Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Maintains Target Price $57
    Market Newswire · 2026/8/3
  • Company notice
    Frazier Life Sciences Acquisition Corp. II | DRS: Others
    SEC · 2026/9/12
  • Company notice
    Leonardo DRS, Inc. | 4: Statement of changes in beneficial ownership of securities-Director TOWNSEND FRANCES F
    SEC · 2026/10/2
  • Rating change
    A Quick Look at Today's Ratings for Leonardo DRS, Inc.(DRS.US), With a Forecast Between $47 to $55
    Market Newswire · 2026/7/31
  • Earnings Flash (DRS) Leonardo DRS, Inc. Reports Q3 Revenue $1.07B, Vs. FactSet Est of $1.03B
    MT Newswires · 2026/10/29
  • Rating change
    Morgan Stanley Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Maintains Target Price $47
    Market Newswire · 2026/7/31

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:27 · For reference only, not investment advice and not tailored to your situation.

Leonardo DRS, Inc. discussion 0 comments

Add a comment